Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DECIDE Registry: AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management

NCT06376851 is registered in ClinicalTrials.gov with HeartFlow, Inc. as lead sponsor.

NCT NCT06376851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06376851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DECIDE Registry: AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
Lead sponsor
HeartFlow, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
March 27, 2024
Completion date
March 27, 2030
Enrollment
20,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease